TNBC tumors and to a lesser degree the HER2+ tumors, readily adapt to growth in mice, whereas only 2.5% of ER+ tumors successfully formed stable patient-derived breast cancer xenografts (28). This evidence concerns the gene ERBB2 and breast carcinoma.